Lesinurad sodium

• CAT Number: I000561
• CAS Number: 1151516-14-1
• Molecular Formula: C17H13BrN3NaO2S
• Molecular Weight: 426.26
• Purity: ≥95%
• Target: URAT1
• Solubility: DMSO: ≥ 29 mg/mL
• Storage: Store at -20°C
• IUPAC Name: sodium;2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetate
• InChI: InChI=1S/C17H14BrN3O2S.Na/c18-16-19-20-17(24-9-15(22)23)21(16)14-8-7-11(10-5-6-10)12-3-1-2-4-13(12)14;/h1-4,7-8,10H,5-6,9H2,(H,22,23);/q;+1/p-1
• InChIKey: FVYMVLTWIBGEMC-UHFFFAOYSA-M
• SMILES: C1CC1C2=CC=C(C3=CC=CC=C23)N4C(=NN=C4Br)SCC(=O)[O-].[Na+]

Lesinurad sodium（Cat No.:I000561）, also known as RDEA594 sodium, is an oral medication that acts as a once-daily inhibitor of the URAT1 transporter. URAT1 is responsible for regulating the excretion of uric acid from the body through the kidneys. By inhibiting URAT1, lesinurad sodium helps to reduce serum uric acid levels, making it a useful treatment for hyperuricemia associated with gout.